Cargando…

Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma

BACKGROUND: The aim of this study is to investigate the anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma. METHODS: The anticancer activity of streptochlorin was evaluated in vitro in various cholangiocarcinoma cell lines for apoptosis, proliferation, invasiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwak, Tae Won, Shin, Hee Jae, Jeong, Young-Il, Han, Myoung-Eun, Oh, Sae-Ock, Kim, Hyun-Jung, Kim, Do Hyung, Kang, Dae Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404940/ https://www.ncbi.nlm.nih.gov/pubmed/25931814 http://dx.doi.org/10.2147/DDDT.S80205

Ejemplares similares

Discovery of Novel Pimprinine and Streptochlorin Derivatives as Potential Antifungal Agents
por: Liu, Jing-Rui, et al.
Publicado: (2022)

Anti-Inflammatory Effect of Streptochlorin via TRIF-Dependent Signaling Pathways in Cellular and Mouse Models
por: Shim, Do-Wan, et al.
Publicado: (2015)

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016)

Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells
por: Kwak, Tae Won, et al.
Publicado: (2013)

Streptochlorin Suppresses Allergic Dermatitis and Mast Cell Activation via Regulation of Lyn/Fyn and Syk Signaling Pathways in Cellular and Mouse Models
por: Lee, Seung-Hwan, et al.
Publicado: (2013)

Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2015)

Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
por: Kim, Do Hyung, et al.
Publicado: (2013)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

Defensive mechanism in cholangiocarcinoma cells against oxidative stress induced by chlorin e6-based photodynamic therapy
por: Lee, Hye Myeong, et al.
Publicado: (2014)

Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells
por: Kim, Cy Hyun, et al.
Publicado: (2013)

Design, Synthesis, Antifungal Activity, and Molecular Docking of Streptochlorin Derivatives Containing the Nitrile Group
por: Liu, Jing-Rui, et al.
Publicado: (2023)

Expression and roles of NUPR1 in cholangiocarcinoma cells
por: Kim, Ki-Sun, et al.
Publicado: (2012)

Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma
por: Baek, Sungmin, et al.
Publicado: (2011)

Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2017)

The molecular mechanism for nuclear transport and its application
por: Kim, Yun Hak, et al.
Publicado: (2017)

Antineoplastic and Immunosuppressive Agents—Part 1
por: Lajtha, L. G.
Publicado: (1975)

Extravasation of Antineoplastic Agents: Prevention and Treatments
por: Boschi, Rita, et al.
Publicado: (2012)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

Gastric stem cells and gastric cancer stem cells
por: Han, Myoung-Eun, et al.
Publicado: (2013)

Gold(III)–pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents**
por: Nardon, Chiara, et al.
Publicado: (2015)

Oral Antineoplastic Agents: Assessing the Delay in Care
por: Anders, Brandi, et al.
Publicado: (2015)

Computer-aided predictions of potential antineoplastic agents
por: Zakharov, Alexey, et al.
Publicado: (2008)

Design and Synthesis of Organic Molecules as Antineoplastic Agents
por: Boga, Carla, et al.
Publicado: (2020)

Prognostic Value of MicroRNAs in Coronary Artery Diseases: A Meta-Analysis
por: Kim, Ji Suk, et al.
Publicado: (2018)

CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells
por: Baek, Sungmin, et al.
Publicado: (2010)

Genetic heterogeneity of liver cancer stem cells
por: Kim, Minjeong, et al.
Publicado: (2023)

Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience
por: Lee, Min-Young, et al.
Publicado: (2021)

Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma
por: Goh, Tae Sik, et al.
Publicado: (2019)

Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells
por: Kim, Cy Hyun, et al.
Publicado: (2011)

Development of a risk scoring system for patients with papillary thyroid cancer
por: Pak, Kyoungjune, et al.
Publicado: (2019)

Development of an aptamer-conjugated fluorescent nanoprobe for MMP2
por: Han, Myoung-Eun, et al.
Publicado: (2014)

Early effects of the antineoplastic agent salinomycin on mitochondrial function
por: Managò, A, et al.
Publicado: (2015)

Editor’s choice 2019: Oxidative stress and antineoplastic agents
por: Ghallab, Ahmed
Publicado: (2020)

Large-scale functional brain networks for consciousness
por: Han, Myoung-Eun, et al.
Publicado: (2021)

Efficient Preparation of Streptochlorin from Marine Streptomyces sp. SYYLWHS-1-4 by Combination of Response Surface Methodology and High-Speed Counter-Current Chromatography
por: Li, Lin, et al.
Publicado: (2016)

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
por: Lee, Kyung-Hun, et al.
Publicado: (2015)

Anticancer Drug-Incorporated Layered Double Hydroxide Nanohybrids and Their Enhanced Anticancer Therapeutic Efficacy in Combination Cancer Treatment
por: Kim, Tae-Hyun, et al.
Publicado: (2014)

Integrated epigenomic analyses of enhancer as well as promoter regions in gastric cancer
por: Baek, Su-Jin, et al.
Publicado: (2016)

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
por: Roizin-Towle, L. A., et al.
Publicado: (1981)

Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment
por: McDowell, Anthony, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v73k2op3flg1f966frjndobpuq